Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Saulo J A, Felizola"'
Autor:
Ichiro Tatsuno, Ikki Sakuma, Seiichiro Higuchi, Akitoshi Nakayama, Ai Tamura, Hidekazu Nagano, Minoru Takemoto, Tomoaki Tanaka, Koutaro Yokote, Hisashi Koide, Naoko Hashimoto, Tomohiko Yoshida, Saulo J A Felizola
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 105:399-406
Context Hashimoto’s thyroiditis is the most common cause of hypothyroidism. Patients usually respond well to oral synthetic thyroxine (levothyroxine); however, for unknown reasons some individuals present with treatment-resistant Hashimoto thyroidi
Autor:
Nobushige Takeshita, Yoshihiro Kubota, Kazuki Ishiwata, Saulo J A Felizola, Seiichiro Higuchi, Tomohiko Ichikawa, Tomoaki Tanaka, Naoko Hashimoto, Masanori Fujimoto, Hisashi Koide, Takashi Uno, Yasuhiro Nakamura, Sawako Suzuki, Toshiaki Ban, Takashi Kono, Atsushi Saiga, Koutaro Yokote, Shinichi Sakamoto, Hidekazu Nagano, Ikki Sakuma, Ai Tamura
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 105:e319-e327
Objective Accurate assessment and localization of aldosterone-producing adenomas (APAs) are essential for the treatment of primary aldosteronism (PA). Although adrenal venous sampling (AVS) is the standard method of reference for subtype diagnosis in
Autor:
Yasuhiro, Nakamura, Saulo J A, Felizola, Fumitoshi, Satoh, Sachiko, Konosu-Fukaya, Hironobu, Sasano
Publikováno v:
Pathology international. 64(10)
The great majority of the cases clinically diagnosed as primary aldosteronism (PA) have been caused by aldosterone-producing adenoma (APA) or idiopathic hyperaldosteronism (IHA). The differential diagnosis of both subtypes of PA is important due to t
Autor:
Monica S M, Chan, Shi-Fan, Chen, Saulo J A, Felizola, Lin, Wang, Noriko, Nemoto, Kentaro, Tamaki, Takanori, Ishida, Louis W C, Chow, Noriaki, Ohuchi, Hironobu, Sasano
Publikováno v:
The International journal of biological markers. 29(3)
The two most important factors in tumor-stromal interactions are tumor-infiltrating lymphocytes (TIL) and neoangiogenesis (NAng). While changes of these parameters in responders of neoadjuvant chemotherapy (NCTx) have been reported, their correlation
Autor:
Yasuhiro, Nakamura, Saulo J A, Felizola, Yumi, Kurotaki, Fumiyoshi, Fujishima, Keely M, McNamara, Takashi, Suzuki, Yoichi, Arai, Hironobu, Sasano
Publikováno v:
The Prostate. 73(6)
Estrogen receptor beta (ERβ) has been demonstrated to be expressed in prostate carcinoma cells and estrogen signals through ERβ to act as a tumor suppressor in prostate cancer patients. ERβ is thought to regulate the cell cycle of prostate carcino